financetom
Business
financetom
/
Business
/
Natural Gas Falls Off One-Month High Even Amid Forecasts for Hot End to August
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Natural Gas Falls Off One-Month High Even Amid Forecasts for Hot End to August
Aug 20, 2024 6:49 AM

09:28 AM EDT, 08/20/2024 (MT Newswires) -- Natural gas fell off a one-month high early on Tuesday despite hot long-term forecasts and lower supply.

Gas for September delivery was last seen down US$0.02 to US$2.22 per million British thermal units after rising on Monday to the highest since July 22.

The drop comes even as long-term forecasts from the National Weather Service expect a hot end to August, with the agency's six to 10-day outlook seeing most states east of the Rocky Mountains with above-seasonal temperatures over the period.

"While national demand [for natural gas] has eased to only moderate levels through Friday, a hotter vs normal pattern is expected to set up this weekend into next week for very strong national demand," NatGasWeather noted.

Supply has also eased, with data from S&P Global Platts provided by the U.S. Natural Gas Supply Association showing producers currently supplying 106.8 billion-cubic feet per day, down from 108.4 bcf a week earlier.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Cardlytics (CDLX) Stock Is Down 30%
Why Cardlytics (CDLX) Stock Is Down 30%
Mar 26, 2024
Cardlytics Inc ( CDLX ) shares are trading lower by 34.6% to $13.24 during Tuesday’s session after the company announced a $150 million proposed convertible senior notes offering. The company says it plans to offer $150.0 million aggregate principal amount of convertible senior notes due 2029 in a private offering to qualified institutional buyers. The notes will be unsecured obligations,...
Why Neubase Therapeutics (NBSE) Shares Are Nosediving
Why Neubase Therapeutics (NBSE) Shares Are Nosediving
Mar 26, 2024
Neubase Therapeutics Inc ( NBSE ) shares are trading lower by 53% to $0.47 during Tuesday’s session after the company on Monday announced it is holding a Special Meeting of Stockholders on May 13, online, to discuss and vote on the proposed liquidation and dissolution of the company, along with an adjournment proposal if necessary. The Board of Directors unanimously...
Verrica Pharmaceuticals' Ycanth Gets New Chemical Entity Status, Orange Book Listing
Verrica Pharmaceuticals' Ycanth Gets New Chemical Entity Status, Orange Book Listing
Mar 26, 2024
02:41 PM EDT, 03/26/2024 (MT Newswires) -- Verrica Pharmaceuticals ( VRCA ) said Tuesday its lead product, Ycanth, has received New Chemical Entity status and a listing in the Orange Book from the US Food and Drug Administration. While NCE status will provide Ycanth with a minimum of five years of protection, we anticipate our full patent portfolio to provide...
Stoke Therapeutics Rises After Investigational Drug Shows Improvement in Dravet Syndrome Patients
Stoke Therapeutics Rises After Investigational Drug Shows Improvement in Dravet Syndrome Patients
Mar 26, 2024
02:42 PM EDT, 03/26/2024 (MT Newswires) -- Stoke Therapeutics ( STOK ) shares were up 68% in recent Tuesday trading, a day after the company reported its investigational new medicine STK-001 was found to benefit subjects with Dravet syndrome, a severe myoclonic epilepsy of infancy. STK-001 was shown to reduce seizures and improve multiple measures of cognition and behavior in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved